REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorios Richmond Colombia S.A.S (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Laboratorios Richmond Colombia S.A.S Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Fabricación propia y encomendada a terceros, de productos farmacéuticos para uso humano, veterinarios y cosmeticos, asi como su comercialización, venta,.

Headquarters
Calle 71 C 29 B 07
Bogota D.C.; Bogota D.C;

Contact Details: Purchase the Laboratorios Richmond Colombia S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Laboratorios Richmond Colombia S.A.S report to view the information.
Outstanding Shares:
Purchase the Laboratorios Richmond Colombia S.A.S report to view the information.
Registered Capital:
Purchase the Laboratorios Richmond Colombia S.A.S report to view the information.
Incorporation Date:
March 28, 1990
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Deputy Member of the Board of Directors
Purchase this report to view the information.
Deputy Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Laboratorios Richmond Colombia S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
9.14%
Total operating revenue
9.05%
Operating profit (EBIT)
-25.34%
EBITDA
-14.65%
Net Profit (Loss) for the Period
N/A
Total assets
13.42%
Total equity
13.82%
Operating Profit Margin (ROS)
-3.39%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
76.86%
Quick Ratio
0.06%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?